FO
GILD icon

FT Options’s Gilead Sciences GILD Stock Holding History

FT Options’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$92K Buy
+60,000
New +$4.59M 0.14% 103
2016
Q4 		– Sell
-137,700
Closed -$57K – 289
2016
Q3 		$57K Buy
137,700
+90,400
+191% +$7.34M 0.05% 199
2016
Q2 		$77K Sell
47,300
-34,800
-42% -$3.09M 0.07% 173
2016
Q1 		$218K Buy
82,100
+57,100
+228% +$5.15M 0.23% 80
2015
Q4 		$190K Buy
+25,000
New +$2.6M 0.14% 106

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FT Options's GILD Position: Q3 2017 in Review

FT Options opened a new position in Gilead Sciences (GILD) in Q3 2017: 11,581 shares worth $938K. The stake represents 1.41% of the portfolio and ranks #24 among its holdings. This is a return to the name: FT Options previously reported a position in GILD as recently as Q4 2016.

FT Options first reported a position in GILD in Q4 2015 and has held it in 6 quarters since. The position peaked at $12.7M in Q4 2015. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • FT Options held 11,581 shares of Gilead Sciences worth $938K as of Q3 2017.
  • Gilead Sciences was a new FT Options position in Q3 2017.
  • Gilead Sciences made up 1.41% of FT Options's portfolio in Q3 2017, its #24 holding.
  • FT Options first reported a position in Gilead Sciences in Q4 2015 and has held it in 6 quarters since.
  • FT Options's Gilead Sciences position peaked at $12.7M in Q4 2015.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.